

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.43244303 |
| 2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.79409008 |
| 3 | skin morphogenesis (GO:0043589) | 3.62368754 |
| 4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.61284015 |
| 5 | cell adhesion mediated by integrin (GO:0033627) | 3.56961470 |
| 6 | urea cycle (GO:0000050) | 3.55927533 |
| 7 | urea metabolic process (GO:0019627) | 3.55927533 |
| 8 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.48495918 |
| 9 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.41768045 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.41561960 |
| 11 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28706666 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28408619 |
| 13 | complement activation, alternative pathway (GO:0006957) | 3.27265752 |
| 14 | phospholipid homeostasis (GO:0055091) | 3.24681768 |
| 15 | cardiac myofibril assembly (GO:0055003) | 3.24109436 |
| 16 | kynurenine metabolic process (GO:0070189) | 3.19998435 |
| 17 | lymphangiogenesis (GO:0001946) | 3.19553098 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.16929926 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.16291125 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.16291125 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.16291125 |
| 22 | regulation of protein activation cascade (GO:2000257) | 3.15147892 |
| 23 | regulation of fibrinolysis (GO:0051917) | 3.13020273 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 3.11316663 |
| 25 | carnitine shuttle (GO:0006853) | 3.02114783 |
| 26 | tryptophan metabolic process (GO:0006568) | 3.00688057 |
| 27 | desmosome organization (GO:0002934) | 2.98467621 |
| 28 | fatty acid transmembrane transport (GO:1902001) | 2.98001373 |
| 29 | nucleobase catabolic process (GO:0046113) | 2.94962532 |
| 30 | collagen fibril organization (GO:0030199) | 2.94714105 |
| 31 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.94674087 |
| 32 | regulation of complement activation (GO:0030449) | 2.93629539 |
| 33 | regulation of plasminogen activation (GO:0010755) | 2.92223488 |
| 34 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.91899954 |
| 35 | cell communication involved in cardiac conduction (GO:0086065) | 2.90768749 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 2.85965891 |
| 37 | cardiac muscle hypertrophy (GO:0003300) | 2.85069979 |
| 38 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.84712760 |
| 39 | chondrocyte proliferation (GO:0035988) | 2.84489676 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 2.84454794 |
| 41 | myofibril assembly (GO:0030239) | 2.83768985 |
| 42 | plasma membrane repair (GO:0001778) | 2.77700270 |
| 43 | regulation of sarcomere organization (GO:0060297) | 2.76002404 |
| 44 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.72497175 |
| 45 | positive regulation of muscle hypertrophy (GO:0014742) | 2.72497175 |
| 46 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.72214384 |
| 47 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.71712545 |
| 48 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.71702120 |
| 49 | protein carboxylation (GO:0018214) | 2.71497695 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71497695 |
| 51 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.70898533 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 2.69101323 |
| 53 | regulation of cell communication by electrical coupling (GO:0010649) | 2.68468543 |
| 54 | COPII vesicle coating (GO:0048208) | 2.68283530 |
| 55 | metanephric mesenchyme development (GO:0072075) | 2.66680232 |
| 56 | triglyceride homeostasis (GO:0070328) | 2.65136694 |
| 57 | acylglycerol homeostasis (GO:0055090) | 2.65136694 |
| 58 | striated muscle hypertrophy (GO:0014897) | 2.64478588 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 2.63506704 |
| 60 | phospholipid efflux (GO:0033700) | 2.62993857 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 2.62447829 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60399238 |
| 63 | L-phenylalanine catabolic process (GO:0006559) | 2.60399238 |
| 64 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.59346496 |
| 65 | negative regulation of lipase activity (GO:0060192) | 2.59087088 |
| 66 | epoxygenase P450 pathway (GO:0019373) | 2.57009243 |
| 67 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.56888400 |
| 68 | regulation of sequestering of triglyceride (GO:0010889) | 2.56113371 |
| 69 | cholesterol efflux (GO:0033344) | 2.54928639 |
| 70 | reverse cholesterol transport (GO:0043691) | 2.54109060 |
| 71 | kidney mesenchyme development (GO:0072074) | 2.53954459 |
| 72 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.53700919 |
| 73 | hemidesmosome assembly (GO:0031581) | 2.53099030 |
| 74 | regulation of axon guidance (GO:1902667) | 2.52898040 |
| 75 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.52113648 |
| 76 | cardiac conduction (GO:0061337) | 2.51546480 |
| 77 | omega-hydroxylase P450 pathway (GO:0097267) | 2.51092110 |
| 78 | substrate-dependent cell migration (GO:0006929) | 2.50606517 |
| 79 | adult heart development (GO:0007512) | 2.49074446 |
| 80 | forebrain neuron development (GO:0021884) | 2.47757296 |
| 81 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.47047419 |
| 82 | exogenous drug catabolic process (GO:0042738) | 2.46366100 |
| 83 | bile acid and bile salt transport (GO:0015721) | 2.44923971 |
| 84 | lymph vessel development (GO:0001945) | 2.44836646 |
| 85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.44013945 |
| 86 | cellular biogenic amine catabolic process (GO:0042402) | 2.43558551 |
| 87 | amine catabolic process (GO:0009310) | 2.43558551 |
| 88 | regulation of relaxation of muscle (GO:1901077) | 2.43087506 |
| 89 | negative regulation of fatty acid transport (GO:2000192) | 2.42785314 |
| 90 | vocalization behavior (GO:0071625) | 2.41491373 |
| 91 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.40796481 |
| 92 | smooth muscle tissue development (GO:0048745) | 2.40623103 |
| 93 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.40445994 |
| 94 | endodermal cell differentiation (GO:0035987) | 2.39886027 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 2.39632364 |
| 96 | muscle hypertrophy (GO:0014896) | 2.39111646 |
| 97 | response to pheromone (GO:0019236) | 2.38247437 |
| 98 | glutamate metabolic process (GO:0006536) | 2.37710485 |
| 99 | positive regulation of fatty acid oxidation (GO:0046321) | 2.36962603 |
| 100 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.35204944 |
| 101 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.35058786 |
| 102 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.34864493 |
| 103 | bile acid biosynthetic process (GO:0006699) | 2.34751440 |
| 104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34687966 |
| 105 | L-phenylalanine metabolic process (GO:0006558) | 2.34687966 |
| 106 | positive regulation of protein autophosphorylation (GO:0031954) | 2.34644582 |
| 107 | homocysteine metabolic process (GO:0050667) | 2.34433817 |
| 108 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34206548 |
| 109 | regulation of cardiac muscle contraction (GO:0055117) | 2.33314115 |
| 110 | amino-acid betaine metabolic process (GO:0006577) | 2.32950784 |
| 111 | macroautophagy (GO:0016236) | 2.32594705 |
| 112 | indolalkylamine metabolic process (GO:0006586) | 2.32271909 |
| 113 | drug catabolic process (GO:0042737) | 2.32042051 |
| 114 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.31400348 |
| 115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.30854225 |
| 116 | glomerulus development (GO:0032835) | 2.29824195 |
| 117 | tyrosine metabolic process (GO:0006570) | 2.29262710 |
| 118 | adrenergic receptor signaling pathway (GO:0071875) | 2.29043259 |
| 119 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.28877410 |
| 120 | sarcomere organization (GO:0045214) | 2.28079941 |
| 121 | gonadal mesoderm development (GO:0007506) | 2.28033653 |
| 122 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.27584973 |
| 123 | neuron remodeling (GO:0016322) | 2.27215579 |
| 124 | positive regulation of heart rate (GO:0010460) | 2.26854351 |
| 125 | protein heterotrimerization (GO:0070208) | 2.26650813 |
| 126 | hippo signaling (GO:0035329) | 2.26440526 |
| 127 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.26260191 |
| 128 | myoblast fusion (GO:0007520) | 2.25671535 |
| 129 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.25404024 |
| 130 | fibrinolysis (GO:0042730) | 2.25389409 |
| 131 | protein-lipid complex remodeling (GO:0034368) | 2.25373150 |
| 132 | macromolecular complex remodeling (GO:0034367) | 2.25373150 |
| 133 | plasma lipoprotein particle remodeling (GO:0034369) | 2.25373150 |
| 134 | cardiac chamber formation (GO:0003207) | 2.25277531 |
| 135 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.25152250 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 2.24907031 |
| 137 | cellular glucuronidation (GO:0052695) | 2.24882348 |
| 138 | cell communication by electrical coupling (GO:0010644) | 2.24722206 |
| 139 | neuron recognition (GO:0008038) | 2.24527327 |
| 140 | paraxial mesoderm development (GO:0048339) | 2.23158006 |
| 141 | regulation of synapse assembly (GO:0051963) | 2.22670086 |
| 142 | positive regulation of glycogen metabolic process (GO:0070875) | 2.22433635 |
| 143 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.20662330 |
| 144 | axon extension involved in axon guidance (GO:0048846) | 2.20662330 |
| 145 | wound healing, spreading of epidermal cells (GO:0035313) | 2.20015256 |
| 146 | negative regulation of wound healing (GO:0061045) | 2.19805898 |
| 147 | venous blood vessel morphogenesis (GO:0048845) | 2.17463968 |
| 148 | artery development (GO:0060840) | 2.15393780 |
| 149 | ganglion development (GO:0061548) | 2.14547391 |
| 150 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.10687335 |
| 151 | sprouting angiogenesis (GO:0002040) | 2.09249484 |
| 152 | apical protein localization (GO:0045176) | 2.08359688 |
| 153 | negative chemotaxis (GO:0050919) | 2.08182858 |
| 154 | endothelial cell morphogenesis (GO:0001886) | 2.07367514 |
| 155 | fibroblast migration (GO:0010761) | 2.07103327 |
| 156 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.05998143 |
| 157 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.04456024 |
| 158 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.03659911 |
| 159 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.03134943 |
| 160 | embryonic foregut morphogenesis (GO:0048617) | 2.02017732 |
| 161 | glomerular visceral epithelial cell development (GO:0072015) | 1.99528081 |
| 162 | negative regulation of axon guidance (GO:1902668) | 1.99326293 |
| 163 | syncytium formation by plasma membrane fusion (GO:0000768) | 1.99009661 |
| 164 | cellular response to vitamin D (GO:0071305) | 1.98445314 |
| 165 | positive regulation of cell junction assembly (GO:1901890) | 1.98234952 |
| 166 | positive regulation of focal adhesion assembly (GO:0051894) | 1.98234952 |
| 167 | positive regulation of adherens junction organization (GO:1903393) | 1.96735334 |
| 168 | gap junction assembly (GO:0016264) | 1.96270180 |
| 169 | chondrocyte development (GO:0002063) | 1.95645097 |
| 170 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 1.95538770 |
| 171 | response to hepatocyte growth factor (GO:0035728) | 1.95538770 |
| 172 | cellular response to vitamin (GO:0071295) | 1.94447271 |
| 173 | * axon extension (GO:0048675) | 1.94407450 |
| 174 | negative regulation of hemostasis (GO:1900047) | 1.94349011 |
| 175 | negative regulation of blood coagulation (GO:0030195) | 1.94349011 |
| 176 | negative regulation of coagulation (GO:0050819) | 1.92895811 |
| 177 | epithelial cell-cell adhesion (GO:0090136) | 1.92759511 |
| 178 | basement membrane organization (GO:0071711) | 1.92602216 |
| 179 | coronary vasculature morphogenesis (GO:0060977) | 1.89485870 |
| 180 | collagen metabolic process (GO:0032963) | 1.89131688 |
| 181 | cell-substrate junction assembly (GO:0007044) | 1.87938561 |
| 182 | semaphorin-plexin signaling pathway (GO:0071526) | 1.87292266 |
| 183 | positive regulation of glycolytic process (GO:0045821) | 1.86581854 |
| 184 | multicellular organismal macromolecule metabolic process (GO:0044259) | 1.85072561 |
| 185 | endothelial cell chemotaxis (GO:0035767) | 1.84013766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54837470 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.03250319 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31841223 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30298323 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13289428 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.12160246 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09216404 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90531779 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88695734 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86348653 |
| 11 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.85493703 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84516853 |
| 13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82635889 |
| 14 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81202155 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80679508 |
| 16 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.79986086 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76404114 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75078925 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.74053800 |
| 20 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.73882271 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71055947 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69051763 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.69025717 |
| 24 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68568469 |
| 25 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67573988 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67513766 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67513766 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66657260 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.65817741 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.65805463 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63806138 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63369049 |
| 33 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.63042908 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62192859 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61354705 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57027803 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56450649 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56052821 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55557912 |
| 40 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.55177337 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54744277 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53248870 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.47051280 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44834694 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44144056 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43165322 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40803274 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40302180 |
| 49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38477684 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38389426 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37636484 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36897594 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35685474 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33307583 |
| 55 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33147267 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31574041 |
| 57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31493436 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31486480 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31451340 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30769246 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30257393 |
| 62 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29963759 |
| 63 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26149449 |
| 64 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.25506489 |
| 65 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25397118 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24381845 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24381845 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24121670 |
| 69 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23751922 |
| 70 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23692454 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23485400 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23378571 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22873900 |
| 74 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22853426 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22655672 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22607492 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21646399 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21047313 |
| 79 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20971373 |
| 80 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20839083 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20764298 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20663313 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20078185 |
| 84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19694587 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19666320 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19500256 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19212753 |
| 88 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18848174 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18332356 |
| 90 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17946507 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17483465 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16884634 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16717582 |
| 94 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16007355 |
| 95 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14610191 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14138511 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14108597 |
| 98 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13792410 |
| 99 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13792410 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13647048 |
| 101 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12897066 |
| 102 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12816489 |
| 103 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12567087 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12530445 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12509500 |
| 106 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12428480 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12392964 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12247079 |
| 109 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11876675 |
| 110 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11606207 |
| 111 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11598223 |
| 112 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10877476 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10639895 |
| 114 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.10332368 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09626996 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09613304 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09147393 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09043777 |
| 119 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08757933 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08458885 |
| 121 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07950943 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07928384 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07915839 |
| 124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05040298 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04917211 |
| 126 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04508285 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03531893 |
| 128 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03430099 |
| 129 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02602688 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02408518 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01961098 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01384228 |
| 133 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01255842 |
| 134 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01104641 |
| 135 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00417735 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99237296 |
| 137 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99204496 |
| 138 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.99194364 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98559425 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97863396 |
| 141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97321452 |
| 142 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96684380 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96655243 |
| 144 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96402097 |
| 145 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96126677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.20594053 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.16238555 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.66800150 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.21263583 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.08924528 |
| 6 | MP0005365_abnormal_bile_salt | 2.82745036 |
| 7 | MP0003252_abnormal_bile_duct | 2.64304034 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.59696090 |
| 9 | MP0000751_myopathy | 2.48954586 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.38897366 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.35937739 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32830628 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.31246945 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.25679442 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.21999146 |
| 16 | MP0000516_abnormal_urinary_system | 2.12118436 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 2.12118436 |
| 18 | MP0005670_abnormal_white_adipose | 2.07394304 |
| 19 | MP0000749_muscle_degeneration | 2.02999250 |
| 20 | MP0001958_emphysema | 2.02257045 |
| 21 | MP0003880_abnormal_central_pattern | 1.99027657 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.97558155 |
| 23 | MP0003279_aneurysm | 1.93349246 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.92477968 |
| 25 | MP0006054_spinal_hemorrhage | 1.85568971 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.81045626 |
| 27 | MP0009697_abnormal_copulation | 1.77616212 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.77515972 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.75252474 |
| 30 | MP0003646_muscle_fatigue | 1.71983220 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.70622330 |
| 32 | MP0005409_darkened_coat_color | 1.70050083 |
| 33 | MP0004085_abnormal_heartbeat | 1.68286055 |
| 34 | MP0002896_abnormal_bone_mineralization | 1.64865130 |
| 35 | MP0004484_altered_response_of | 1.61948563 |
| 36 | MP0001299_abnormal_eye_distance/ | 1.60700383 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.59857582 |
| 38 | MP0001188_hyperpigmentation | 1.59196840 |
| 39 | MP0003137_abnormal_impulse_conducting | 1.56096551 |
| 40 | MP0004130_abnormal_muscle_cell | 1.55984484 |
| 41 | MP0004510_myositis | 1.55722952 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.53585331 |
| 43 | MP0005083_abnormal_biliary_tract | 1.53010018 |
| 44 | MP0005330_cardiomyopathy | 1.52196258 |
| 45 | MP0005503_abnormal_tendon_morphology | 1.51870608 |
| 46 | MP0003283_abnormal_digestive_organ | 1.51153198 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.48962936 |
| 48 | MP0000538_abnormal_urinary_bladder | 1.47633102 |
| 49 | MP0005023_abnormal_wound_healing | 1.47431832 |
| 50 | MP0001879_abnormal_lymphatic_vessel | 1.43011149 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.41307837 |
| 52 | MP0006138_congestive_heart_failure | 1.40189756 |
| 53 | MP0005248_abnormal_Harderian_gland | 1.38765938 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.38103211 |
| 55 | MP0003868_abnormal_feces_composition | 1.38027189 |
| 56 | MP0002060_abnormal_skin_morphology | 1.37425988 |
| 57 | MP0004272_abnormal_basement_membrane | 1.36549535 |
| 58 | MP0003941_abnormal_skin_development | 1.35702869 |
| 59 | MP0000534_abnormal_ureter_morphology | 1.35097269 |
| 60 | MP0005275_abnormal_skin_tensile | 1.33689107 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.31751912 |
| 62 | MP0002168_other_aberrant_phenotype | 1.26967014 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.26448500 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.26006022 |
| 65 | MP0001542_abnormal_bone_strength | 1.22643425 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.22044233 |
| 67 | MP0002254_reproductive_system_inflammat | 1.19598681 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.19340491 |
| 69 | MP0005385_cardiovascular_system_phenoty | 1.19103257 |
| 70 | MP0001544_abnormal_cardiovascular_syste | 1.19103257 |
| 71 | MP0005620_abnormal_muscle_contractility | 1.18373654 |
| 72 | MP0009053_abnormal_anal_canal | 1.15357776 |
| 73 | MP0003828_pulmonary_edema | 1.15335549 |
| 74 | MP0002736_abnormal_nociception_after | 1.14684600 |
| 75 | MP0000003_abnormal_adipose_tissue | 1.14615269 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 1.13822752 |
| 77 | MP0002127_abnormal_cardiovascular_syste | 1.11654968 |
| 78 | MP0010630_abnormal_cardiac_muscle | 1.11324479 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.10473062 |
| 80 | MP0000462_abnormal_digestive_system | 1.09964895 |
| 81 | MP0005595_abnormal_vascular_smooth | 1.06639200 |
| 82 | MP0000733_abnormal_muscle_development | 1.06431594 |
| 83 | MP0005171_absent_coat_pigmentation | 1.03659819 |
| 84 | MP0000566_synostosis | 1.01991348 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.00568088 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.00544217 |
| 87 | MP0000383_abnormal_hair_follicle | 0.99756235 |
| 88 | MP0000579_abnormal_nail_morphology | 0.99275788 |
| 89 | MP0004036_abnormal_muscle_relaxation | 0.98693021 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.95445399 |
| 91 | MP0000778_abnormal_nervous_system | 0.95349282 |
| 92 | MP0003385_abnormal_body_wall | 0.94809118 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.94649492 |
| 94 | MP0003942_abnormal_urinary_system | 0.91491866 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.91284349 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.91108776 |
| 97 | MP0000762_abnormal_tongue_morphology | 0.90698251 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.90404714 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.90045100 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.89734316 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.89392800 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.88268877 |
| 103 | MP0001915_intracranial_hemorrhage | 0.86755484 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.86715001 |
| 105 | MP0003755_abnormal_palate_morphology | 0.86096034 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.85919398 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.85786539 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.84804548 |
| 109 | MP0002572_abnormal_emotion/affect_behav | 0.84396650 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.84192596 |
| 111 | MP0005448_abnormal_energy_balance | 0.83815788 |
| 112 | MP0003045_fibrosis | 0.82646972 |
| 113 | MP0004233_abnormal_muscle_weight | 0.82135581 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.81155971 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.79969423 |
| 116 | MP0004134_abnormal_chest_morphology | 0.79228208 |
| 117 | MP0003935_abnormal_craniofacial_develop | 0.78610983 |
| 118 | MP0002971_abnormal_brown_adipose | 0.78450810 |
| 119 | MP0000537_abnormal_urethra_morphology | 0.77737941 |
| 120 | MP0000432_abnormal_head_morphology | 0.77373886 |
| 121 | MP0005197_abnormal_uvea_morphology | 0.77145109 |
| 122 | MP0001486_abnormal_startle_reflex | 0.76545573 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.76009961 |
| 124 | MP0003122_maternal_imprinting | 0.75928648 |
| 125 | MP0002128_abnormal_blood_circulation | 0.75093140 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.74637296 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.73635550 |
| 128 | MP0000467_abnormal_esophagus_morphology | 0.73499663 |
| 129 | MP0009046_muscle_twitch | 0.73289621 |
| 130 | MP0004381_abnormal_hair_follicle | 0.73235164 |
| 131 | MP0005369_muscle_phenotype | 0.72773765 |
| 132 | MP0002282_abnormal_trachea_morphology | 0.72709275 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.72534576 |
| 134 | MP0009745_abnormal_behavioral_response | 0.72076948 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.71903776 |
| 136 | MP0000163_abnormal_cartilage_morphology | 0.71837790 |
| 137 | MP0000428_abnormal_craniofacial_morphol | 0.71550821 |
| 138 | MP0005395_other_phenotype | 0.70906125 |
| 139 | MP0005334_abnormal_fat_pad | 0.70065592 |
| 140 | MP0004270_analgesia | 0.69934915 |
| 141 | MP0002184_abnormal_innervation | 0.69628625 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.69386134 |
| 143 | MP0004924_abnormal_behavior | 0.69386134 |
| 144 | MP0003195_calcinosis | 0.69338634 |
| 145 | MP0002269_muscular_atrophy | 0.68635756 |
| 146 | MP0001614_abnormal_blood_vessel | 0.68457978 |
| 147 | MP0002925_abnormal_cardiovascular_devel | 0.68434093 |
| 148 | MP0004019_abnormal_vitamin_homeostasis | 0.68130485 |
| 149 | MP0003091_abnormal_cell_migration | 0.68080195 |
| 150 | MP0003115_abnormal_respiratory_system | 0.67672490 |
| 151 | MP0004858_abnormal_nervous_system | 0.67362147 |
| 152 | MP0005187_abnormal_penis_morphology | 0.67252151 |
| 153 | MP0000427_abnormal_hair_cycle | 0.66991142 |
| 154 | MP0001243_abnormal_dermal_layer | 0.65514651 |
| 155 | MP0002557_abnormal_social/conspecific_i | 0.65457744 |
| 156 | MP0001177_atelectasis | 0.64579869 |
| 157 | MP0009840_abnormal_foam_cell | 0.63676260 |
| 158 | MP0003191_abnormal_cellular_cholesterol | 0.62983687 |
| 159 | MP0003937_abnormal_limbs/digits/tail_de | 0.62732243 |
| 160 | MP0002233_abnormal_nose_morphology | 0.62628258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Calf muscle hypertrophy (HP:0008981) | 4.64414122 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.54118120 |
| 3 | Sudden death (HP:0001699) | 4.52943250 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.34498495 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.13999304 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.04344225 |
| 7 | Vascular tortuosity (HP:0004948) | 3.80655026 |
| 8 | Arterial tortuosity (HP:0005116) | 3.72016476 |
| 9 | Febrile seizures (HP:0002373) | 3.67253518 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.65701437 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 3.63902808 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.59284619 |
| 13 | Aortic dissection (HP:0002647) | 3.58587920 |
| 14 | Syncope (HP:0001279) | 3.58093011 |
| 15 | Atrial fibrillation (HP:0005110) | 3.51912221 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.40982795 |
| 17 | Ventricular tachycardia (HP:0004756) | 3.33072789 |
| 18 | Primary atrial arrhythmia (HP:0001692) | 3.32193692 |
| 19 | Complement deficiency (HP:0004431) | 3.31293475 |
| 20 | Epidermoid cyst (HP:0200040) | 3.16524661 |
| 21 | Atrophic scars (HP:0001075) | 3.14654537 |
| 22 | Aortic aneurysm (HP:0004942) | 3.08358054 |
| 23 | Supraventricular tachycardia (HP:0004755) | 3.03084273 |
| 24 | Fair hair (HP:0002286) | 3.01574775 |
| 25 | Hyperventilation (HP:0002883) | 3.00263469 |
| 26 | Neonatal short-limb short stature (HP:0008921) | 2.99780499 |
| 27 | Supraventricular arrhythmia (HP:0005115) | 2.99061011 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 2.97943311 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.91486106 |
| 30 | Cardiovascular calcification (HP:0011915) | 2.83685742 |
| 31 | Overgrowth (HP:0001548) | 2.81447632 |
| 32 | Soft skin (HP:0000977) | 2.80773647 |
| 33 | Joint hemorrhage (HP:0005261) | 2.79337572 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 2.66482573 |
| 35 | Xanthomatosis (HP:0000991) | 2.66082116 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.65987653 |
| 37 | Shallow orbits (HP:0000586) | 2.64497991 |
| 38 | Hypoventilation (HP:0002791) | 2.60328515 |
| 39 | Abnormality of dentin (HP:0010299) | 2.58918689 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58238602 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54504172 |
| 42 | Skin nodule (HP:0200036) | 2.53031802 |
| 43 | Hypoplastic ischia (HP:0003175) | 2.52536432 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.52488980 |
| 45 | Prolonged QT interval (HP:0001657) | 2.52363615 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50910871 |
| 47 | Popliteal pterygium (HP:0009756) | 2.50265597 |
| 48 | Abnormality of the ischium (HP:0003174) | 2.49788147 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.45463709 |
| 50 | Cervical subluxation (HP:0003308) | 2.44178051 |
| 51 | Mitral valve prolapse (HP:0001634) | 2.42249032 |
| 52 | EMG: myopathic abnormalities (HP:0003458) | 2.37968165 |
| 53 | Abnormality of complement system (HP:0005339) | 2.37936018 |
| 54 | Focal motor seizures (HP:0011153) | 2.36450768 |
| 55 | Lipoatrophy (HP:0100578) | 2.36148697 |
| 56 | Wormian bones (HP:0002645) | 2.34429292 |
| 57 | Vascular calcification (HP:0004934) | 2.33454283 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.33319700 |
| 59 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.25499318 |
| 60 | Subaortic stenosis (HP:0001682) | 2.25499318 |
| 61 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.24963628 |
| 62 | Glomerulonephritis (HP:0000099) | 2.24954190 |
| 63 | Absent speech (HP:0001344) | 2.24812574 |
| 64 | Short nail (HP:0001799) | 2.24399350 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.23895252 |
| 66 | Wrist flexion contracture (HP:0001239) | 2.22213589 |
| 67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21991300 |
| 68 | Cerebral aneurysm (HP:0004944) | 2.21088522 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.20481820 |
| 70 | Broad metatarsal (HP:0001783) | 2.19989814 |
| 71 | Fragile skin (HP:0001030) | 2.19132313 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 2.14932769 |
| 73 | Ankle contracture (HP:0006466) | 2.13203147 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.12484803 |
| 75 | Abnormality of the nasal septum (HP:0000419) | 2.11734464 |
| 76 | Bradycardia (HP:0001662) | 2.10242693 |
| 77 | Increased connective tissue (HP:0009025) | 2.09857427 |
| 78 | Myocardial infarction (HP:0001658) | 2.09323502 |
| 79 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07791116 |
| 80 | Genu recurvatum (HP:0002816) | 2.07789643 |
| 81 | Bundle branch block (HP:0011710) | 2.07471557 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.07144556 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.07144556 |
| 84 | Hyperextensible skin (HP:0000974) | 2.07042783 |
| 85 | Bladder diverticulum (HP:0000015) | 2.06967383 |
| 86 | Ventricular arrhythmia (HP:0004308) | 2.06381703 |
| 87 | Striae distensae (HP:0001065) | 2.05843117 |
| 88 | Exotropia (HP:0000577) | 2.05505306 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 2.04464332 |
| 90 | Heart block (HP:0012722) | 2.03561410 |
| 91 | Excessive salivation (HP:0003781) | 2.02572055 |
| 92 | Drooling (HP:0002307) | 2.02572055 |
| 93 | Aortic regurgitation (HP:0001659) | 2.01759139 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.00514930 |
| 95 | Tibial bowing (HP:0002982) | 2.00514883 |
| 96 | Spinal rigidity (HP:0003306) | 1.97881600 |
| 97 | Blue irides (HP:0000635) | 1.97054504 |
| 98 | Abnormality of incisor morphology (HP:0011063) | 1.95941183 |
| 99 | Vertebral arch anomaly (HP:0008438) | 1.94896757 |
| 100 | Type 1 muscle fiber predominance (HP:0003803) | 1.93256169 |
| 101 | Abnormal EKG (HP:0003115) | 1.91872098 |
| 102 | Submucous cleft hard palate (HP:0000176) | 1.91708561 |
| 103 | Obstructive sleep apnea (HP:0002870) | 1.91188954 |
| 104 | Aneurysm (HP:0002617) | 1.90082291 |
| 105 | Nephritis (HP:0000123) | 1.89252432 |
| 106 | Hypoplasia of the iris (HP:0007676) | 1.88462209 |
| 107 | Vitreoretinal degeneration (HP:0000655) | 1.88027497 |
| 108 | Atrioventricular block (HP:0001678) | 1.87727928 |
| 109 | Limited hip movement (HP:0008800) | 1.87377195 |
| 110 | Natal tooth (HP:0000695) | 1.86323842 |
| 111 | Spondylolisthesis (HP:0003302) | 1.85900124 |
| 112 | Spontaneous abortion (HP:0005268) | 1.83684784 |
| 113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.83011115 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82352056 |
| 115 | Difficulty climbing stairs (HP:0003551) | 1.82302611 |
| 116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80385227 |
| 117 | Abnormal delivery (HP:0001787) | 1.78676252 |
| 118 | Osteoarthritis (HP:0002758) | 1.78069541 |
| 119 | Abnormality of methionine metabolism (HP:0010901) | 1.78021083 |
| 120 | Absent frontal sinuses (HP:0002688) | 1.77739869 |
| 121 | Focal seizures (HP:0007359) | 1.77504931 |
| 122 | Progressive cerebellar ataxia (HP:0002073) | 1.77343172 |
| 123 | Broad-based gait (HP:0002136) | 1.75952350 |
| 124 | Mild short stature (HP:0003502) | 1.75742602 |
| 125 | Impaired social interactions (HP:0000735) | 1.75062048 |
| 126 | Abnormal social behavior (HP:0012433) | 1.75062048 |
| 127 | Hyperammonemia (HP:0001987) | 1.74799501 |
| 128 | Muscle fiber splitting (HP:0003555) | 1.73818352 |
| 129 | Coronal craniosynostosis (HP:0004440) | 1.73779530 |
| 130 | Pulmonary artery stenosis (HP:0004415) | 1.73550901 |
| 131 | Muscular dystrophy (HP:0003560) | 1.73349706 |
| 132 | Follicular hyperkeratosis (HP:0007502) | 1.73096931 |
| 133 | Alopecia of scalp (HP:0002293) | 1.73075279 |
| 134 | Hypochromic microcytic anemia (HP:0004840) | 1.73002374 |
| 135 | Hypophosphatemic rickets (HP:0004912) | 1.72472161 |
| 136 | Epileptic encephalopathy (HP:0200134) | 1.71698428 |
| 137 | Joint laxity (HP:0001388) | 1.71578259 |
| 138 | Mitral stenosis (HP:0001718) | 1.71356642 |
| 139 | Sleep apnea (HP:0010535) | 1.70762045 |
| 140 | Abnormality of the right ventricle (HP:0001707) | 1.70466514 |
| 141 | Papillary thyroid carcinoma (HP:0002895) | 1.69579229 |
| 142 | Wide anterior fontanel (HP:0000260) | 1.69430806 |
| 143 | Genetic anticipation (HP:0003743) | 1.69322052 |
| 144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69173924 |
| 145 | Pulmonic stenosis (HP:0001642) | 1.68607289 |
| 146 | Lymphangioma (HP:0100764) | 1.68225155 |
| 147 | Hyperglycemia (HP:0003074) | 1.67574087 |
| 148 | Round ear (HP:0100830) | 1.67044831 |
| 149 | Aortic valve stenosis (HP:0001650) | 1.66981870 |
| 150 | Ketosis (HP:0001946) | 1.66297510 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.66214585 |
| 152 | Hip contracture (HP:0003273) | 1.66090280 |
| 153 | Advanced eruption of teeth (HP:0006288) | 1.62722012 |
| 154 | Pterygium (HP:0001059) | 1.62624890 |
| 155 | Bowel diverticulosis (HP:0005222) | 1.59677954 |
| 156 | Buphthalmos (HP:0000557) | 1.59405554 |
| 157 | Asymmetry of the thorax (HP:0001555) | 1.58844067 |
| 158 | Morphological abnormality of the middle ear (HP:0008609) | 1.58767327 |
| 159 | Cubitus valgus (HP:0002967) | 1.57694010 |
| 160 | Blue sclerae (HP:0000592) | 1.56505053 |
| 161 | Ovoid vertebral bodies (HP:0003300) | 1.53475925 |
| 162 | Infantile muscular hypotonia (HP:0008947) | 1.53338572 |
| 163 | Spinal cord compression (HP:0002176) | 1.53190523 |
| 164 | Knee flexion contracture (HP:0006380) | 1.51278178 |
| 165 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.51026728 |
| 166 | Congenital glaucoma (HP:0001087) | 1.50971411 |
| 167 | Abnormality of the acetabulum (HP:0003170) | 1.49352018 |
| 168 | Peritonitis (HP:0002586) | 1.48669320 |
| 169 | Mitral regurgitation (HP:0001653) | 1.48577097 |
| 170 | Ulnar bowing (HP:0003031) | 1.47762682 |
| 171 | Arthropathy (HP:0003040) | 1.45281947 |
| 172 | Dilatation of the ascending aorta (HP:0005111) | 1.44519573 |
| 173 | Hydroxyprolinuria (HP:0003080) | 1.42024735 |
| 174 | Abnormality of proline metabolism (HP:0010907) | 1.42024735 |
| 175 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.40849019 |
| 176 | Vertebral compression fractures (HP:0002953) | 1.39685413 |
| 177 | Delayed gross motor development (HP:0002194) | 1.39282514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.67005544 |
| 2 | INSRR | 2.40659219 |
| 3 | NTRK1 | 2.36137201 |
| 4 | MET | 2.28600816 |
| 5 | CAMK1D | 2.16098213 |
| 6 | LATS1 | 2.13698320 |
| 7 | OBSCN | 2.12605180 |
| 8 | CAMK1G | 2.11583617 |
| 9 | SIK2 | 1.93556206 |
| 10 | PIK3CA | 1.88046537 |
| 11 | AKT3 | 1.85478209 |
| 12 | MUSK | 1.76684584 |
| 13 | ZAK | 1.74126614 |
| 14 | MAP3K4 | 1.68990419 |
| 15 | SGK2 | 1.64914469 |
| 16 | TNIK | 1.64571948 |
| 17 | SIK1 | 1.61821970 |
| 18 | NTRK3 | 1.61422312 |
| 19 | EPHB2 | 1.60175511 |
| 20 | DAPK2 | 1.59098631 |
| 21 | PNCK | 1.57626112 |
| 22 | MAP2K7 | 1.57288844 |
| 23 | MAP2K4 | 1.53949730 |
| 24 | TTN | 1.53468109 |
| 25 | MOS | 1.52129976 |
| 26 | PLK2 | 1.50965925 |
| 27 | LATS2 | 1.44349991 |
| 28 | EPHA2 | 1.43495870 |
| 29 | EPHA4 | 1.40972895 |
| 30 | CAMK4 | 1.38464698 |
| 31 | BCR | 1.38318565 |
| 32 | TIE1 | 1.38050331 |
| 33 | PHKG1 | 1.36733821 |
| 34 | PHKG2 | 1.36733821 |
| 35 | GRK7 | 1.32283185 |
| 36 | DMPK | 1.27976342 |
| 37 | ERBB4 | 1.27412591 |
| 38 | YES1 | 1.26106039 |
| 39 | ICK | 1.25272671 |
| 40 | LIMK1 | 1.24742147 |
| 41 | SIK3 | 1.24421871 |
| 42 | FRK | 1.23230743 |
| 43 | SGK3 | 1.22892003 |
| 44 | MARK1 | 1.20033177 |
| 45 | FER | 1.19728665 |
| 46 | STK38L | 1.15364694 |
| 47 | STK38 | 1.15336424 |
| 48 | MYLK | 1.14062409 |
| 49 | PAK2 | 1.11823471 |
| 50 | PDGFRA | 1.08175225 |
| 51 | LMTK2 | 1.06326981 |
| 52 | CAMK2A | 1.05119905 |
| 53 | MAP3K7 | 1.04653145 |
| 54 | GRK5 | 1.03326843 |
| 55 | PKN1 | 1.03185186 |
| 56 | STK3 | 1.01983931 |
| 57 | STK24 | 1.00745724 |
| 58 | MAPK13 | 1.00379390 |
| 59 | PRKAA2 | 0.99643452 |
| 60 | MAPK12 | 0.99473813 |
| 61 | CAMK1 | 0.98567076 |
| 62 | WNK1 | 0.96287667 |
| 63 | PRKCE | 0.96255346 |
| 64 | MKNK2 | 0.95771663 |
| 65 | SGK1 | 0.94222998 |
| 66 | ERBB2 | 0.94199575 |
| 67 | ROCK2 | 0.92976594 |
| 68 | MAP3K12 | 0.92104997 |
| 69 | STK39 | 0.90402769 |
| 70 | CAMK2D | 0.89985719 |
| 71 | ERBB3 | 0.88867237 |
| 72 | DDR2 | 0.85832320 |
| 73 | PTK2B | 0.85378687 |
| 74 | MTOR | 0.85005213 |
| 75 | MST1R | 0.83278774 |
| 76 | RIPK1 | 0.82045395 |
| 77 | EIF2AK2 | 0.79453741 |
| 78 | TRPM7 | 0.75798453 |
| 79 | PAK3 | 0.74207521 |
| 80 | NUAK1 | 0.73938982 |
| 81 | RIPK4 | 0.73388561 |
| 82 | MELK | 0.73094630 |
| 83 | GSK3A | 0.71468987 |
| 84 | PAK6 | 0.70502579 |
| 85 | SGK494 | 0.69735967 |
| 86 | SGK223 | 0.69735967 |
| 87 | MAP3K6 | 0.68239352 |
| 88 | MAP3K14 | 0.65454831 |
| 89 | PDGFRB | 0.64968188 |
| 90 | TGFBR2 | 0.64898023 |
| 91 | TAOK3 | 0.64881075 |
| 92 | PRKAA1 | 0.63794052 |
| 93 | TESK1 | 0.63672287 |
| 94 | PKN2 | 0.62889879 |
| 95 | BMPR1B | 0.61808472 |
| 96 | BRD4 | 0.61479927 |
| 97 | PAK4 | 0.61300279 |
| 98 | PRKG1 | 0.61256448 |
| 99 | EPHA3 | 0.60939123 |
| 100 | MAP3K9 | 0.60617189 |
| 101 | MAP3K2 | 0.59257065 |
| 102 | PRKD3 | 0.59078110 |
| 103 | ROCK1 | 0.56243045 |
| 104 | CAMK2B | 0.56153486 |
| 105 | KSR1 | 0.55796504 |
| 106 | RPS6KA2 | 0.55669234 |
| 107 | MAP3K3 | 0.55611385 |
| 108 | STK16 | 0.55578460 |
| 109 | ABL2 | 0.55322596 |
| 110 | PTK2 | 0.54939598 |
| 111 | FGFR3 | 0.54125626 |
| 112 | CAMKK2 | 0.54063515 |
| 113 | MAP3K5 | 0.51626590 |
| 114 | MAPK7 | 0.51420767 |
| 115 | PRPF4B | 0.51382343 |
| 116 | FGFR2 | 0.51281949 |
| 117 | STK11 | 0.49323835 |
| 118 | CDC42BPA | 0.49259546 |
| 119 | PINK1 | 0.48709551 |
| 120 | FGFR1 | 0.46407974 |
| 121 | PBK | 0.46156391 |
| 122 | NEK9 | 0.45643534 |
| 123 | PRKCZ | 0.44997218 |
| 124 | RET | 0.43952841 |
| 125 | AKT2 | 0.43139206 |
| 126 | JAK1 | 0.42796401 |
| 127 | CSNK1A1L | 0.42595877 |
| 128 | EPHB1 | 0.42469218 |
| 129 | PRKG2 | 0.42413403 |
| 130 | PRKCG | 0.41658745 |
| 131 | MINK1 | 0.40802785 |
| 132 | PRKACG | 0.40790748 |
| 133 | EIF2AK3 | 0.40555511 |
| 134 | CDK12 | 0.40287853 |
| 135 | PRKACA | 0.39560451 |
| 136 | PRKD2 | 0.39525131 |
| 137 | CDK5 | 0.38753682 |
| 138 | TRIM28 | 0.38525590 |
| 139 | CAMK2G | 0.36749986 |
| 140 | CSNK1G2 | 0.36363587 |
| 141 | MAP2K1 | 0.36341860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.34676666 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.73110761 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.65293233 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37634176 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12459730 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96144833 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.94157568 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.88078984 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.77652652 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.73236839 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 1.67855953 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67163545 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66107689 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.63782016 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60839773 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55110305 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53894156 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.52794857 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52575984 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49208969 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47652383 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44761177 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40001227 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.36834106 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32968119 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31561006 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29081884 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.27728195 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25358133 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23313199 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20840510 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18876923 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15693441 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14944117 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 1.12739879 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12217361 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09805784 |
| 38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.08968530 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08278231 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07971694 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07647583 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07460331 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06452047 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.06366952 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.05577961 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04347355 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02100480 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01290893 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01171855 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98517916 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97992503 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96678212 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.95039808 |
| 54 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94014852 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93789497 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92447493 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 0.91909088 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.91169072 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90547127 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.89381369 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86548654 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.86474543 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86177739 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84923099 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84655966 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81458032 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81354046 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79826036 |
| 69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79793072 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77636948 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77129750 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76788127 |
| 73 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.75471818 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74444183 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73888367 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.73172898 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72755887 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72709236 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71313357 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70576901 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70373883 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69984079 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69976717 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.69504059 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.68929626 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.68778785 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68046941 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67159322 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67070207 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64729168 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.64723505 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64673070 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64299055 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62159073 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61564704 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61252848 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60634860 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.60443240 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.60426725 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59692624 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59643476 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59284485 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59234785 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58867344 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58022740 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57405033 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57061997 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.56140194 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54510904 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54504427 |
| 111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54476335 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54045265 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53551737 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52959700 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52791955 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51973287 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.51827291 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51326514 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.51181975 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50651741 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.48762138 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.48521005 |
| 123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47483411 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47375700 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46422819 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44213840 |
| 127 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43942671 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.43938546 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43358101 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43199383 |
| 131 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42970304 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42492836 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41357398 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41058088 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.40248422 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37685651 |
| 137 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37579768 |
| 138 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37256401 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35562536 |
| 140 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35018364 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34315352 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32889767 |

